tiprankstipranks
Pharmadrug (TSE:PHRX)
:PHRX
Canadian Market
PHRX
Pharmadrug
RESEARCH TOOLSreports
Want to see TSE:PHRX full AI Analyst Report?

Pharmadrug (PHRX) Financial Statements

33 Followers

Pharmadrug Financial Overview

Pharmadrug's market cap is currently C$1.62M. The company's EPS TTM is C$-0.0009; its P/E ratio is -3.04; Pharmadrug is scheduled to report earnings on May 6, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 7.01KC$ 683.67K
Gross ProfitC$ -50.24KC$ -26.22KC$ -2.26KC$ -2.15KC$ 182.04K
Operating IncomeC$ -668.66KC$ -1.33MC$ -2.43MC$ -2.80MC$ -3.84M
EBITDAC$ -549.04KC$ -1.33MC$ -2.34MC$ -4.21MC$ -4.28M
Net IncomeC$ -793.27KC$ -13.20MC$ -8.88MC$ -5.87MC$ -5.15M
Balance Sheet
Cash & Short-Term InvestmentsC$ 75.04KC$ 423.06KC$ 329.24KC$ 1.30MC$ 4.40M
Total AssetsC$ 711.80KC$ 1.20MC$ 12.11MC$ 19.52MC$ 13.69M
Total DebtC$ 1.35MC$ 1.77MC$ 1.42MC$ 866.37KC$ 1.13M
Net DebtC$ 1.27MC$ 1.36MC$ 1.41MC$ -91.62KC$ -1.01M
Total LiabilitiesC$ 1.96MC$ 2.66MC$ 3.28MC$ 2.66MC$ 3.12M
Stockholders' EquityC$ -1.40MC$ -1.70MC$ 8.84MC$ 16.87MC$ 9.66M
Cash Flow
Free Cash FlowC$ -768.60KC$ -671.88KC$ -2.26MC$ -4.17MC$ -1.43M
Operating Cash FlowC$ -756.62KC$ -671.88KC$ -2.26MC$ -4.13MC$ -1.41M
Investing Cash FlowC$ -11.98KC$ 995.04KC$ 77.58KC$ 1.48MC$ 3.78M
Financing Cash FlowC$ 321.56KC$ 225.51KC$ 843.25KC$ 776.97KC$ 132.24K
Currency in CAD

Pharmadrug Earnings and Revenue History

Income Statement >

Pharmadrug Debt to Assets

Balance Sheet >

Pharmadrug Cash Flow

Cash Flow >

Pharmadrug Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >